Yifei Cheng

Donor‐derived<scp>CD</scp>19‐targeted T cell infusion induces minimal residual disease‐negative remission in relapsed B‐cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation

Yu‐Hong Chen, Yifei Cheng, Pan Suo et al. · British Journal of Haematology · 2017 · 103 citations · Full text

Medicine, Hematology, Immunology +16

Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation

Chen‐Hua Yan, Yu Wang, Xiao‐Dong Mo et al. · Clinical Infectious Diseases · 2018 · 69 citations · Full text

Medicine, Hematology, Infectious Diseases +17

Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma

Yifei Cheng, Xiaofang Chen, Feng Li et al. · Cell Discovery · 2025 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +17

First‐line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy

Yifei Cheng, Zhengli Xu, Yuanyuan Zhang et al. · Clinical Transplantation · 2017 · 42 citations

Medicine, Hematology, Pediatrics +12

Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Yu‐Hong Chen, Xian Zhang, Yifei Cheng et al. · Cytotherapy · 2020 · 42 citations

Medicine, Hematology, Oncology +16